The primary objective of this multi-country noninterventional study is to compare theeffectiveness of galcanezumab to oral migraine preventive standard of care overall in adult patients with migraine who are switching or initiating preventive treatment in clinical practice settings.
We are excited to announce that we are participating in a clinical trial to help change opioid use patterns in subjects with OUD (Opioid Use Disorder). This trial’s goal is to help reduce the use of opioids by providing a “whole-patient” approach to the treatment of OUD.
A phase 2, randomized study to evaluate the efficacy and safety of intra-articular Resiniferatoxin (RTX) to treat moderate to severe pain from knee osteoarthritis (OA). The active comparator is Zilretta.
To evaluate tapering/titration of nabilone in combination with gabapentin (PP-01) for the mitigation of withdrawal symptoms, utilizing the Cannabis Withdrawal Core Symptoms Score (CWCSS), to measure cannabis withdrawal symptoms in participants with moderate to severe cannabis use disorder (CUD) seeking to discontinue cannabis.